Diseases Invest Information

Aeglea BioTherapeutics AGLE Receives Sell Rating Amid Market Dynamics Nov 13, 2023

GENFIT Announces Q3 2023 Financial Results with Cash Reserves and Revenue Insights Nov 10, 2023